Brief: Firebrick Pharma Says Received Notice Of Allowance Of Second Patent In U.S. On Covid-19
04/03/2024 01:00
March 4 (Reuters) - Firebrick Pharma FRE.AX :
* RECEIVED NOTICE OF ALLOWANCE OF SECOND PATENT IN US
RELATING TO
COVID-19
Source text for Eikon: ID:nASX71Bmc3
Further company coverage: FRE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Firebrick Pharma
See all newsAustralia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market
Brief: Firebrick Pharma Receives A$293,000 Research And Development Tax Incentive
Brief: Firebrick Pharma Says Nasodine Composition Patent Granted In New Zealand
Brief: Firebrick Pharma Says Nasodine Patent Accepted In Canada
Brief: Firebrick Pharma Secures A$1.5 Million Via Placement